UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549



                                    FORM 8-K

                                 CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15 (d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934


          Date of Report (Date of earliest event reported) May 1, 2003

                               CONMED CORPORATION

             (Exact name of registrant as specified in its charter)


            New York                        0-16093              16-0977505
(State or other jurisdiction of           (Commission       (I.R.S. Employer
 incorporation or organization)           File Number)       Identification No.)

 525 French Road, Utica, New York                              13502
 (Address of principal executive offices)                      (Zip Code)


                                 (315) 797-8375
              (Registrant's telephone number, including area code)










Item 5.  Other Events

The following  discussion is intended to supplement,  to the extent inconsistent
therewith,  the discussion of the Registrant's  Liquidity and Capital  Resources
included in the Registrant's Form 10-K for the year ended December 31, 2002:

Liquidity and Capital Resources

     Cash  generated  from our  operations  and  borrowings  under our revolving
credit  facility  have  traditionally  provided  the  working  capital  for  our
operations,  debt  service  under our  credit  facility  and the  funding of our
capital expenditures. In addition, we have used term borrowings, including:

        o    borrowings under our senior credit agreement;
        o    Senior Subordinated Notes issued to refinance borrowings under our
             senior credit agreement, in the case of the acquisition of Linvatec
             Corporation in 1997;
        o    borrowings under separate loan facilities, in the case of real
             property acquisitions, to finance our acquisitions.

     We expect to continue to use cash flow from our  operations  and borrowings
under our revolving credit facility to finance our operations,  our debt service
under our new senior credit  facility and term borrowings and the funding of our
capital expenditures.

     During the quarter ended March 31, 2003,  outstanding  borrowings under our
$200 million senior credit agreement (our "senior credit agreement")  increased,
from $105.0  million at December  31, 2002 to $135.5  million at March 31, 2003,
principally as a result of our borrowing  $31.0 million to fund a portion of our
acquisition of Bionx Implants, Inc.

     On May 1, 2003,  we borrowed an  additional  $15.0 million under our senior
credit  agreement to redeem $15 million of our outstanding  Senior  Subordinated
Notes (at a premium of 4.5%),  which have a maturity  date of March 15, 2008 and
bear  interest  at 9.0% per  annum.  Giving  effect  to the  redemption  and the
repurchase of $2.6 million of our Senior  Subordinated  Bonds on the open market
during the first  quarter  of 2003,  $112.4  million of our Senior  Subordinated
Bonds remain outstanding.

     Management  believes that cash generated from operations,  our current cash
resources and funds available under our new senior credit agreement will provide
sufficient  liquidity to ensure continued  working capital for operations,  debt
service  and  funding of capital  expenditures  in the  foreseeable  future.  In
addition, although the outstanding Senior Subordinated Bonds do not mature until
2008,  management  continues to review  alternatives  for redeeming  outstanding
bonds,  including the addition of an additional  term loan tranche to the senior
credit  agreement to redeem all  outstanding  Senior  Subordinated  Bonds at the
applicable redemption price.



                                    Signature

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.



                                                       CONMED CORPORATION



                                                By:/s/ Robert D. Shallish, Jr.
                                                   ---------------------------
                                                   Vice President-Finance and
                                                   Chief Financial Officer



Date:     May 1, 2003